ArticleScientific reports2026
Diversity of specialized metabolites in Phaeoacremonium species revealed by untargeted metabolomics and bioactivity assays.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Fungi belonging to the genus Phaeoacremonium are recognized as cross-kingdom pathogens, that affect both agricultural crops and human health. Here, we report the first comprehensive large-scale chemotaxonomic study based on untargeted MS-based metabolomics of 28 isolates representing 24 Phaeoacremonium species. The chemometric analysis was integrated with in vitro toxicity on human keratinocytes and cucumber (Cucumis sativus) cotyledons, serving as representative models for human and plant hosts, respectively. A targeted LC-MS/MS method validated the production of the naphthoquinones scytalone and isosclerone, previously associated with grapevine trunk diseases, but revealed high interspecific variability in their abundance. Chemometric analysis revealed that cultures of Phaeoacremonium species can be distinguished based on their chemical fingerprints. In total, 206 significant metabolic features were uncovered, spanning several chemical classes including prenol lipids, carboxylic acid derivatives, organooxygen compounds, and macrolides. Nevertheless, 36 metabolites were putatively identified. Under our experimental conditions, scytalone and isosclerone showed negligible cytotoxicity and only mild phytotoxicity. In contrast, several crude extracts gave strong toxic effects, suggesting that activity may depend on complex metabolite interactions rather than single compounds. Notably, extracts from grapevine-associated species displayed stronger phytotoxicity and cytotoxicity compared to those from olive or human sources, highlighting a more diverse or more potent array of bioactive metabolites. Together, these results expand the known chemical space of Phaeoacremonium and underscore the need for targeted in vivo studies to elucidate the ecological roles and potential health implications of their secondary metabolites.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.